A senior government official said the industry has been requesting for an amendment to allow them to implement the price change from the next batch.
Kanika Datta sums up the best of BS Opinion articles: from why the public should be consulted in redesigning New Delhi and why the government must not control drug prices.
Govt should not control drug prices
The Supreme Court has ruled that a hospital trust buying flats to accommodate its nurses could be called a 'consumer' under the Consumer Protection Act
Pharma companies feel that working out an overarching solution for the entire industry is cumbersome and unlikely to work out
Centre likely to consider rationalising trade margins
Industry insiders pointed out that almost 70% of oncology drugs are sold through the hospital channel
Local industry fears global firms will register equipment as 'innovative' to secure price control waiver for 5 years
To make medicines affordable, the government capped prices of 855 medicines and some medical devices, says minister
Indian healthcare sector is prone to various industry practices which have the effect of choking competition
Pharma pricing regulator has asked companies to furnish details of batch-wise production and sales
Proposed amendment to also state formula to decide drug prices
The move reflects growing resistance to rising drug prices around the world
It had fixed ceiling prices of 530 scheduled formulations in accordance with DPCO 2013
But the treatments are least affordable in lower income countries